Correction: Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing (Journal of Allergy and Clinical Immunology (2016) 138(4) (1142–1151)(S0091674916306030)(10.1016/j.jaci.2016.05.035));Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 4, 2016, Pages 1142-1151.e2

  Yu, Hui ^a   Zhang, Victor Wei ^b   Stray Pedersen, Asbjørg ^b,c,d   Hanson, Imelda Celine ^c   Forbes, Lisa R ^c   de la Morena, M Teresa ^e   Chinn, Ivan K ^c   Gorman, Elizabeth ^a   Mendelsohn, Nancy J ^f   Pozos, Tamara ^f   Wiszniewski, Wojciech ^b   Nicholas, Sarah K ^c   Yates, Anne B ^g   Moore, Lindsey E ^g   Berge, Knut Erik ^d   Sorte, Hanne ^d   Bayer, Diana K ^h   ALZahrani, Daifulah ⁱ   Geha, Raif S ^j   Feng, Yanming ^a   Wang, Guoli ^a   Orange, Jordan S ^c   Lupski, James R ^b,c   Wang, Jing ^b   Wong, Lee Jun ^b   more..

^a BAYLOR GENETICS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^g UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^j HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

molecular diagnostics; next generation sequencing; Severe combined immunodeficiency; severe combined immunodeficiency newborn screening

Indexed keywords

ATM PROTEIN; RAG1 PROTEIN; T LYMPHOCYTE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; COPY NUMBER VARIATION; DIAGNOSTIC VALUE; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; INDEL MUTATION; INFANT; MALE; MISSENSE MUTATION; MOLECULAR DIAGNOSTICS; NEWBORN SCREENING; NEXT GENERATION SEQUENCING; NONSENSE MUTATION; PRIORITY JOURNAL; PSEUDOGENE; SEVERE COMBINED IMMUNODEFICIENCY; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; CHILD; DNA SEQUENCE; GENETIC VARIATION; GENETICS; MOLECULAR PATHOLOGY; STANDARDS; TRENDS;

ADOLESCENT; CHILD; FEMALE; GENETIC VARIATION; HUMANS; MALE; PATHOLOGY, MOLECULAR; SEQUENCE ANALYSIS, DNA; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 84992170316     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.11.002     Document Type: Erratum

References (63)

1. 1 Notarangelo, L.D., Primary immunodeficiencies. J Allergy Clin Immunol 125:suppl (2010), S182–S194.
2. 2 Buckley, R.H., Schiff, S.E., Schiff, R.I., Markert, L., Williams, L.W., Roberts, J.L., et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 340 (1999), 508–516.
3. 3 Chan, A., Scalchunes, C., Boyle, M., Puck, J.M., Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey. Clin Immunol 138 (2011), 3–8.
4. 4 Brown, L., Xu-Bayford, J., Allwood, Z., Slatter, M., Cant, A., Davies, E.G., et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood 117 (2011), 3243–3246.
5. 5 Gennery, A.R., Slatter, M.A., Grandin, L., Taupin, P., Cant, A.J., Veys, P., et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?. J Allergy Clin Immunol 126 (2010), 602–610 e1-11.
6. 6 Puck, J.M., Neonatal screening for severe combined immunodeficiency. Curr Opin Pediatr 23 (2011), 667–673.
7. 7 Buckley, R.H., The long quest for neonatal screening for severe combined immunodeficiency. J Allergy Clin Immunol 129 (2012), 597–606.
8. 8 Verbsky, J.W., Baker, M.W., Grossman, W.J., Hintermeyer, M., Dasu, T., Bonacci, B., et al. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011). J Clin Immunol 32 (2012), 82–88.
9. 9 Vogel, B.H., Bonagura, V., Weinberg, G.A., Ballow, M., Isabelle, J., DiAntonio, L., et al. Newborn screening for SCID in New York State: experience from the first two years. J Clin Immunol 34 (2014), 289–303.
10. 10 Verbsky, J., Routes, J., Screening for and treatments of congenital immunodeficiency diseases. Clin Perinatol 41 (2014), 1001–1015.
11. 11 Kwan, A., Church, J.A., Cowan, M.J., Agarwal, R., Kapoor, N., Kohn, D.B., et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J Allergy Clin Immunol 132 (2013), 140–150.
12. 12 Adams, S.P., Rashid, S., Premachandra, T., Harvey, K., Ifederu, A., Wilson, M.C., et al. Screening of neonatal UK dried blood spots using a duplex TREC screening assay. J Clin Immunol 34 (2014), 323–330.
13. 13 Audrain, M., Thomas, C., Mirallie, S., Bourgeois, N., Sebille, V., Rabetrano, H., et al. Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study. Clin Immunol 150 (2014), 137–139.
14. 14 Kwan, A., Abraham, R.S., Currier, R., Brower, A., Andruszewski, K., Abbott, J.K., et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 312 (2014), 729–738.
15. 15 Chan, K., Puck, J.M., Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 115 (2005), 391–398.
16. 16 Buckley, R.H., Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22 (2004), 625–655.
17. 17 Hernandez-Trujillo, V., New genetic discoveries and primary immune deficiencies. Clin Rev Allergy Immunol 46 (2014), 145–153.
18. 18 Picard, C., Al-Herz, W., Bousfiha, A., Casanova, J.L., Chatila, T., Conley, M.E., et al. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol 35 (2015), 696–726.
19. 19 Noguchi, M., Yi, H., Rosenblatt, H.M., Filipovich, A.H., Adelstein, S., Modi, W.S., et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73 (1993), 147–157.
20. 20 Puck, J.M., Pepper, A.E., Henthorn, P.S., Candotti, F., Isakov, J., Whitwam, T., et al. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 89 (1997), 1968–1977.
21. 21 Pai, S.Y., Logan, B.R., Griffith, L.M., Buckley, R.H., Parrott, R.E., Dvorak, C.C., et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med 371 (2014), 434–446.
22. 22 Wong, M.T., Scholvinck, E.H., Lambeck, A.J., van Ravenswaaij-Arts, C.M., CHARGE syndrome: a review of the immunological aspects. Eur J Hum Genet 23 (2015), 1451–1459.
23. 23 Gennery, A.R., Immunological aspects of 22q11.2 deletion syndrome. Cell Mol Life Sci 69 (2012), 17–27.
24. 24 Ram, G., Chinen, J., Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 164 (2011), 9–16.
25. 25 Nijman, I.J., van Montfrans, J.M., Hoogstraat, M., Boes, M.L., van de Corput, L., Renner, E.D., et al. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol 133 (2014), 529–534.
26. 26 Stoddard, J.L., Niemela, J.E., Fleisher, T.A., Rosenzweig, S.D., Targeted NGS: a cost-effective approach to molecular diagnosis of PIDs. Front Immunol, 5, 2014, 531.
27. 27 Moens, L.N., Falk-Sorqvist, E., Asplund, A.C., Bernatowska, E., Smith, C.I., Nilsson, M., Diagnostics of primary immunodeficiency diseases: a sequencing capture approach. PLoS One, 9, 2014, e114901.
28. 28 Wang, J., Cui, H., Lee, N.C., Hwu, W.L., Chien, Y.H., Craigen, W.J., et al. Clinical application of massively parallel sequencing in the molecular diagnosis of glycogen storage diseases of genetically heterogeneous origin. Genet Med 15 (2012), 106–114.
29. 29 Wang, J., Zhang, V.W., Feng, Y., Tian, X., Li, F.Y., Truong, C., et al. Dependable and efficient clinical utility of target capture-based deep sequencing in molecular diagnosis of retinitis pigmentosa. Invest Ophthalmol Vis Sci 55 (2014), 6213–6223.
30. 30 Feng, Y., Chen, D., Wang, G.L., Zhang, V.W., Wong, L.J., Improved molecular diagnosis by the detection of exonic deletions with target gene capture and deep sequencing. Genet Med 17 (2014), 99–107.
31. 31 Al-Herz, W., Bousfiha, A., Casanova, J.L., Chatila, T., Conley, M.E., Cunningham-Rundles, C., et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol, 5, 2014, 162.
32. 32 Yagi, H., Furutani, Y., Hamada, H., Sasaki, T., Asakawa, S., Minoshima, S., et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 362 (2003), 1366–1373.
33. 33 Ogata, T., Niihori, T., Tanaka, N., Kawai, M., Nagashima, T., Funayama, R., et al. TBX1 mutation identified by exome sequencing in a Japanese family with 22q11.2 deletion syndrome-like craniofacial features and hypocalcemia. PLoS One, 9, 2014, e91598.
34. 34 Lindsay, E.A., Vitelli, F., Su, H., Morishima, M., Huynh, T., Pramparo, T., et al. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410 (2001), 97–101.
35. 35 Merscher, S., Funke, B., Epstein, J.A., Heyer, J., Puech, A., Lu, M.M., et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104 (2001), 619–629.
36. 36 Paylor, R., Glaser, B., Mupo, A., Ataliotis, P., Spencer, C., Sobotka, A., et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci U S A 103 (2006), 7729–7734.
37. 37 Markert, M.L., Marques, J.G., Neven, B., Devlin, B.H., McCarthy, E.A., Chinn, I.K., et al. First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases. Blood 117 (2011), 688–696.
38. 38 Su, D.M., Navarre, S., Oh, W.J., Condie, B.G., Manley, N.R., A domain of Foxn1 required for crosstalk-dependent thymic epithelial cell differentiation. Nat Immunol 4 (2003), 1128–1135.
39. 39 Schuddekopf, K., Schorpp, M., Boehm, T., The whn transcription factor encoded by the nude locus contains an evolutionarily conserved and functionally indispensable activation domain. Proc Natl Acad Sci U S A 93 (1996), 9661–9664.
40. 40 Campbell, I.M., Shaw, C.A., Stankiewicz, P., Lupski, J.R., Somatic mosaicism: implications for disease and transmission genetics. Trends Genet 31 (2015), 382–392.
41. 41 Kavadas, F.D., Giliani, S., Gu, Y., Mazzolari, E., Bates, A., Pegoiani, E., et al. Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations. J Allergy Clin Immunol 122 (2008), 1178–1184.
42. 42 van Zelm, M.C., Geertsema, C., Nieuwenhuis, N., de Ridder, D., Conley, M.E., Schiff, C., et al. Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements. Am J Hum Genet 82 (2008), 320–332.
43. 43 Alsmadi, O., Al-Ghonaium, A., Al-Muhsen, S., Arnaout, R., Al-Dhekri, H., Al-Saud, B., et al. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia. BMC Med Genet, 10, 2009, 116.
44. 44 Pannicke, U., Honig, M., Schulze, I., Rohr, J., Heinz, G.A., Braun, S., et al. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events. Hum Mutat 31 (2010), 197–207.
45. 45 Boone, P.M., Campbell, I.M., Baggett, B.C., Soens, Z.T., Rao, M.M., Hixson, P.M., et al. Deletions of recessive disease genes: CNV contribution to carrier states and disease-causing alleles. Genome Res 23 (2013), 1383–1394.
46. 46 Reith, W., Mach, B., The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 19 (2001), 331–373.
47. 47 Bontron, S., Steimle, V., Ucla, C., Eibl, M.M., Mach, B., Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum Genet 99 (1997), 541–546.
48. 48 Felgentreff, K., Perez-Becker, R., Speckmann, C., Schwarz, K., Kalwak, K., Markelj, G., et al. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol 141 (2011), 73–82.
49. 49 Schuetz, C., Niehues, T., Friedrich, W., Schwarz, K., Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID). Autoimmun Rev 9 (2010), 477–482.
50. 50 De, P., Rodgers, K.K., Putting the pieces together: identification and characterization of structural domains in the V(D)J recombination protein RAG1. Immunol Rev 200 (2004), 70–82.
51. 51 Lee, Y.N., Frugoni, F., Dobbs, K., Walter, J.E., Giliani, S., Gennery, A.R., et al. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol 133 (2014), 1099–1108.
52. 52 Niehues, T., Perez-Becker, R., Schuetz, C., More than just SCID–the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2. Clin Immunol 135 (2010), 183–192.
53. 53 Tsuda, M., Torgerson, T.R., Selmi, C., Gambineri, E., Carneiro-Sampaio, M., Mannurita, S.C., et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 35 (2010), 265–268.
54. 54 Martin-Santiago, A., Hervas, J.A., Hervas, D., Rosell, A., Caimari, M., de Carlos, J.C., et al. Diagnostic value of the skin lesions in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Dermatol 30 (2013), e221–e222.
55. 55 Shearer, W.T., Dunn, E., Notarangelo, L.D., Dvorak, C.C., Puck, J.M., Logan, B.R., et al. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol 133 (2014), 1092–1098.
56. 56 Markert, M.L., Devlin, B.H., Alexieff, M.J., Li, J., McCarthy, E.A., Gupton, S.E., et al. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood 109 (2007), 4539–4547.
57. 57 Bayer, D.K., Martinez, C.A., Sorte, H.S., Forbes, L.R., Demmler-Harrison, G.J., Hanson, I.C., et al. Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol 178 (2014), 459–469.
58. 58 Lupski, J.R., Structural variation mutagenesis of the human genome: impact on disease and evolution. Environ Mol Mutagen 56 (2015), 419–436.
59. 59 Mallott, J., Kwan, A., Church, J., Gonzalez-Espinosa, D., Lorey, F., Tang, L.F., et al. Newborn screening for SCID identifies patients with ataxia telangiectasia. J Clin Immunol 33 (2013), 540–549.
60. 60 Leuzzi, V., Micheli, R., D'Agnano, D., Molinaro, A., Venturi, T., Plebani, A., et al. Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia. Neurol Neuroimmunol Neuroinflamm, 2, 2015, e98.
61. 61 Kuo, C.Y., Chase, J., Garcia Lloret, M., Stiehm, E.R., Moore, T., Aguilera, M.J., et al. Newborn screening for severe combined immunodeficiency does not identify bare lymphocyte syndrome. J Allergy Clin Immunol 131 (2013), 1693–1695.
62. 62 Grazioli, S., Bennett, M., Hildebrand, K.J., Vallance, H., Turvey, S.E., Junker, A.K., Limitation of TREC-based newborn screening for ZAP70 Severe Combined Immunodeficiency. Clin Immunol 153 (2014), 209–210.
63. 63 Jilkina, O., Thompson, J.R., Kwan, L., Van Caeseele, P., Rockman-Greenberg, C., Schroeder, M.L., Retrospective TREC testing of newborns with Severe Combined Immunodeficiency and other primary immunodeficiency diseases. Mol Genet Metab Rep 1 (2014), 324–333.